Ethical Considerations in Clinical Chemistry and Laboratory Medicine
Christine B. Sekadde-Kigondu, BSc Biochemistry, PhD, FAPath ECSA,
Department of Human Pathology, Thematic Unit of Clinical Chemistry, School of Medicine,
College of Health Sciences, University of Nairobi, P.O. Box 19676, Nairobi 00202, Kenya.
Trefor Higgins, M Sc. FCACB.
Director of Clinical Chemistry
DynaLFEDx
Canada
David E. Bruns, M.D.
Department of Pathology,
University of Virginia School of Medicine,
Charlottesville, VA, USA
Ann M. Gronowski, PhD
Washington University School of Medicine
St Louis, MO USA
For the IFCC Task Force on Ethics (TF-E)

Tam metin için tıklayınız

Table of Contents
1. Aim of the Report................................................................................................. 3
2. Introduction.......................................................................................................... 3
3. Ethical Issues in the Pre-analytical Phase........................................................... 6
4. Ethical Issues in the Analytical Phase ................................................................. 9
5. Ethical Issues in the Post Analytical Phase....................................................... 11
6. References ........................................................................................................ 14
7. Further Reading ................................................................................................ 16

Comments: (0)